Drug of choice of paroxysmal supraventricular tachycardia is –
The drug of choice for PSVT is adenosine. Adenosine works by activating A1 adenosine receptors in the AV node, which leads to a decrease in the conduction velocity and a prolongation of the refractory period. This can terminate the reentrant circuit responsible for PSVT. Adenosine is preferred because it acts quickly and has a short half-life, so its effects are transient.
Now, looking at the options, the correct answer should be adenosine. Let's consider the other options. Verapamil is a calcium channel blocker that can also be used, but it's not the first-line. Beta-blockers like metoprolol might be used in certain cases, but again, adenosine is the first choice. Amiodarone is used for more severe cases or when other options aren't effective.
The clinical pearl here is that adenosine is the first-line treatment because of its rapid onset and minimal side effects. Students should remember the A1 receptor activation and the AV node's role in PSVT. So, the correct answer is adenosine.
**Core Concept**
Paroxysmal supraventricular tachycardia (PSVT) arises from reentrant pathways in the AV node or accessory pathways. The drug of choice must rapidly block AV nodal conduction to terminate the arrhythmia. Adenosine, a purinergic agonist, is preferred for its rapid onset and short half-life.
**Why the Correct Answer is Right**
Adenosine activates Aβ adenosine receptors in the AV node, causing potassium efflux and hyperpolarization. This slows AV nodal conduction velocity and prolongs the refractory period, interrupting reentrant circuits in PSVT. Its effects last seconds, minimizing systemic side effects. It is administered as a fast IV push (6 mg initially), making it ideal for acute termination of PSVT.
**Why Each Wrong Option is Incorrect**
**Option A:** Verapamil (calcium channel blocker) is a second-line agent for PSVT. It inhibits AV nodal conduction but has slower onset and risks hypotension.
**Option B:** Beta-blockers (e.g., metoprolol) may be used in stable patients but are not first-line due to slower action and contraindications in asthma.
**Option D:** Amiodarone is reserved for refractory cases or when structural heart disease is present. It has a slower onset and more side effects than adenosine.
**Clinical Pearl / High-Yield Fact**
Adenosine is the **first-line agent** for PSVT due to its rapid action and safety profile. Remember the **"6-12-12" protocol**: 6 mg IV push, repeat 12 mg if ineffective, with a max dose of 12 mg. Avoid in WPW syndrome (pre-excited rhythms) due to risk of ventricular fibrillation.
**